Blog - Page 1298 of 5718

WednesdayJul 21, 2021 11:06 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Establishes New Subsidiary, Provides Update on Anticipated Acquisition

Pressure BioSciences (OTCQB: PBIO) has established a wholly owned agrochemicals subsidiary; the subsidiary will be named PBI Agrochem Inc. and is designed to house the announced asset acquisition from Global Agrochemicals Innovator. PBIO previously announced the acquisition of Global Agrochemicals Innovator, a global developer and supplier of environmentally responsible and organically natural agrochemicals, and anticipates completing that transaction in the coming weeks. In addition, PBIO announced that it has purchased specialized, proprietary material worth more than $500,000 to be used to fulfill initial demand for its ecofriendly, agrochemical pest control and growth stimulant products. "We have developed a very aggressive…

WednesdayJul 21, 2021 10:45 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Demonstrates Significantly Enhanced Delivery of Colchicine

Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its tolerability and pharmacokinetic study VIRAL-A20-3 has been completed with positive results. According to the update, the study demonstrated that DehydraTECH(TM)-enabled colchicine, the latest of several drugs Lexaria has successfully tested with known SARS-CoV-2 antiviral properties, benefited from the company’s proprietary formulation and processing, resulting in significantly increased delivery. The study also examined absorption with two other antiviral drugs previously untested by Lexaria; however, the bloodstream delivery findings were unremarkable and further work is required should the company decide to pursue additional testing with…

WednesdayJul 21, 2021 10:24 am

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), University of Michigan to Collaborate in Phase 2a Clinical Trial for Fibromyalgia

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs through accelerated regulatory pathways, today announced its plans to conduct a phase 2a clinical trial with the Chronic Pain & Fatigue Research Center in the Department of Anesthesiology at the University of Michigan Medical School. According to the update, the open-label trial will evaluate the efficacy of TRYP-8802, an oral formulation of synthetic psilocybin, in tandem with psychotherapy for treating fibromyalgia. The treatment is designed to leverage the neuroplasticity benefits of psilocybin to target nociplastic pain originating in the central…

WednesdayJul 21, 2021 9:43 am

QualityStocksNewsBreaks – Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Announces Historically High Productivity Rates for Platosa Mine

Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) today announced second quarter 2021 production results from the Platosa Mine in Durango, Mexico. Among the highlights, the company reported silver equivalent (“AgEq”) production of 487,009 oz. In addition, Platosa achieved its fourth consecutive quarter of over 21,000 tonnes mined and milled, with record tonnes mined (86,316) and milled (88,648) over the trailing twelve months. “Platosa delivered a fourth consecutive quarter of production at historically high productivity rates,” said Brendan Cahill, president and CEO of Excellon Resources. “We continue to see room for improvement, with our ongoing work to improve recoveries at…

WednesdayJul 21, 2021 9:30 am

The DeFi Conference 2021 Tackles The Challenges of the Decentralized Finance Industry

5th August 2021 Pricing-Free The Decentralized Finance (“DeFi”) Industry offers a vast set of opportunities and has its set of challenges, with market finance volatility and risks increasing accordingly. The DeFi Conference 2021 is being held on 5th August 2021. This one-day free online event is a great learning and informative platform for businesses, academics, investors, and entrepreneurs to better understand the decentralized finance industry and explore the opportunities that this space offers. The DeFi Conference 2021 is organized by Bitcoin Events, a pioneer events company that hosts world-class bitcoin and blockchain conferences in Africa. The event will bring forth…

WednesdayJul 21, 2021 9:30 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) to Begin Patient Dosing in Berubicin Phase 2 Clinical Trial During Q3 2021, and Received Fast Track Designation from FDA

CNS Pharmaceuticals has been granted FDA Fast Track Designation for Berubicin due to the serious unmet medical need for new GBM treatments Enrollment into the potentially pivotal study for Berubicin and glioblastoma multiforme (“GBM”) in adults is already underway CNS Pharmaceuticals also secures additional funding of $4.7 million for pivotal study and operations into Q2 2022, adding to company’s significant accomplishments in short time CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, achieved several fundamental clinical, corporate, and regulatory milestones over the…

WednesdayJul 21, 2021 9:00 am

Friendable Inc. (FDBL) Reports Major Milestone of 5,000 Fan Pass Artist Sign-ups, Shares New Corporate Presentation

The new version of the Fan Pass platform (v2.0) for mobile and desktop is scheduled for release one year after its debut, with new and improved offerings outlined in a new corporate presentation Artists and fans both benefit from the updated version, gaining an easy-to-use dashboard that tracks ticket and merchandise sales (for artists) and special access into the lives of the artists (for fans) Friendable estimates that if three celebrity partners with 10 million followers each marketed the Fan Pass platform and 1% of those followers subscribed, that would bring 300,000 new subscribers to the artist streaming platform A…

WednesdayJul 21, 2021 9:00 am

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Looks to Leverage Position in Growing Infused-Cannabis Space

New numbers project that cannabis beverage market will reach $2.8 billion by 2025 Increasing demand for the health and wellness drinks is contributing to market growth BevCanna’s scalable, flexible manufacturing process provides white label solutions for third-party companies A new report that forecasts the cannabis beverage market will grow at 17.85% CAGR by 2025 has companies such as BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) anticipating increased numbers as well (https://ibn.fm/zh9Pa). A leader in the space, BevCanna is looking to leverage its position in the growing market as a white label manufacturer of infused-cannabis beverage brands. According to a…

WednesdayJul 21, 2021 9:00 am

Keynote Speaker Presentations from SRAX Inc.’s (NASDAQ: SRAX) 2021 Sequire Blockchain Conference Now Available on Demand

2021 Sequire Blockchain Conference presentations now available on demand Conference featured over 15 established and emerging companies across blockchain, cryptocurrency spaces Keynote speakers included Brock Pierce, Maja Vujinovic, Saum Noursalehi, George Stella, Brittany Kaiser SRAX (NASDAQ: SRAX), a leading financial technology company that helps public companies unlock the power of data through its Sequire SaaS platform, recently hosted the 2021 Sequire Blockchain Conference (https://ibn.fm/fTW6e), featuring over 15 leading blockchain and cryptocurrency-focused companies along with a slew of industry experts, including Brock Pierce, Maja Vujinovic, Saum Noursalehi, George Stella and Brittany Kaiser. Brock Pierce is a prominent entrepreneur, philanthropist, blockchain pioneer,…

TuesdayJul 20, 2021 2:53 pm

QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Announces Issuance of New US Patents

Kaival Brands (OTCQB: KAVL) is the exclusive global distributor of products manufactured by Bidi Vapor LLC, including the BIDI (R) Stick disposable electronic nicotine delivery system (“ENDS”), which is intended exclusively for adults 21 and over. Today the company announced that the United States Patent and Trademark Office (“USPTO”) has issued two additional U.S. patents to Bidi(R) Vapor: patent numbers 11,064,735 and 11,064,736. In addition, patent numbers 11,013,261 and 10,932,491, which were previously pending, have also been granted. “These newly issued patents add valuable coverage to our growing patent portfolio and in our opinion represent the future of the electronic…

Site Search

Company Search

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Establishes New Subsidiary, Provides Update on Anticipated Acquisition

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Demonstrates Significantly Enhanced Delivery of Colchicine

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF), University of Michigan to Collaborate in Phase 2a Clinical Trial for Fibromyalgia

QualityStocksNewsBreaks – Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FSE: E4X2) Announces Historically High Productivity Rates for Platosa Mine

The DeFi Conference 2021 Tackles The Challenges of the Decentralized Finance Industry

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) to Begin Patient Dosing in Berubicin Phase 2 Clinical Trial During Q3 2021, and Received Fast Track Designation from FDA

Friendable Inc. (FDBL) Reports Major Milestone of 5,000 Fan Pass Artist Sign-ups, Shares New Corporate Presentation

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Looks to Leverage Position in Growing Infused-Cannabis Space

Keynote Speaker Presentations from SRAX Inc.’s (NASDAQ: SRAX) 2021 Sequire Blockchain Conference Now Available on Demand

QualityStocksNewsBreaks – Kaival Brands Innovations Group Inc. (KAVL) Announces Issuance of New US Patents

Market Basics

Newsletter Publishers

Public Companies